Skip to main content
AAO-HNSF 2023 Annual Meeting & OTO Experience Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Rhinology/Allergy

ICAR Sinonasal Tumors, Part 1: Principles and Benign Lesions

Wednesday, October 4, 2023
8:00 AM - 9:00 AM East Coast USA Time
Location: 102AB

    Moderator(s)

  • MW

    Marilene B. Wang, MD

    Professor
    UCLA Head and Neck Surgery
    Los Angeles, CA, United States

    • Panelist(s)

  • Edward C. Kuan, MD

    Associate Professor
    UC Irvine
    Orange, CA, United States

  • JP

    James N. Palmer, MD

    Professor
    University of Pennsylvania
    Philadelphia, PA, United States

  • Nithin D. Adappa, MD

    Associate Professor
    Department of Otorhinolaryngology – Head & Neck Surgery, University of Pennsylvania
    Philadelphia, PA, United States

Disclosure(s):
Marilene B. Wang, MD: No relevant relationships to disclose.
Edward C. Kuan, MD: No relevant relationships to disclose.
Nithin D. Adappa, MD: No relevant relationships to disclose.
PROGRAM DESCRIPTION: Program

Description: Management of sinonasal tumors may be challenging due to the complex anatomy of the sinonasal region and proximity to critical neurovascular structures. Furthermore, due to the rarity of these tumor types, treatment guidelines and recommendations may be difficult to define. As such, a multidisciplinary, international consortium of experts has convened to develop an international consensus statement on sinonasal tumors (ICSNT). There are 30 topics in the consensus statement, which were developed by an editorial team, and expert authors from all over the world were invited to perform systematic or literature reviews. In addition, the statement includes an Executive Summary and detailed description of the methods, which followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Evidence-based reviews (EBR) or evidence-based reviews with recommendations (EBRR) were developed and underwent iterative reviews by two associate editors until consensus was achieved. Topics included epidemiology, diagnostic workup, imaging, pathology, surgical approaches and complications, adjuvant therapies, prognosis, quality of life, and surveillance. This panel will be comprised of the editors and associate editors of this consensus statement, and highlights from the statement will be discussed. We will focus on general principles related to sinonasal oncology, such as resectability, management of the orbit, and margin analysis, and on benign sinonasal tumors, including vascular lesions, papillomas, orbital masses, and other rare benign neoplasms. Summaries and recommendations, when appropriate, for specific tumor types will be addressed. These guidelines will be highly relevant for otolaryngologists as they manage patients with sinonasal tumors. Finally, research and future directions for treatment of benign sinonasal tumors will be discussed.

OUTCOME OBJECTIVE 1: 1. To review the methodology of ICAR: Sinonasal Tumors.

OUTCOME OBJECTIVE 2: 2. To summarize the literature surrounding general oncologic principles related to sinonasal tumors.

OUTCOME OBJECTIVE 3: 3. To understand the rationale for evidence-based reviews with recommendations for treatment of benign sinonasal tumors

BACKGROUND STATEMENT: Benign sinonasal tumors are relatively rare, and literature regarding management is sparse. An international consensus statement from expert authors is a critically important tool for optimal work-up and management of these tumors.